House Energy & Commerce Subcommittee Issues Testimony From AdvaMedDx Executive Director Rothstein
March 28, 2024
March 28, 2024
WASHINGTON, March 28 -- The House Energy and Commerce Subcommittee on Health issued the following written testimony by AdvaMedDx Executive Director Zach Rothstein involving a hearing on March 21, 2024, entitled "Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA's Proposed Rule." FDA is the Food and Drug Administration.
* * *
Good morning and thank you, Chairwoman McMorris Rodgers, Ranking Member Pallone, Subcommittee Chair Guthrie, . . .
* * *
Good morning and thank you, Chairwoman McMorris Rodgers, Ranking Member Pallone, Subcommittee Chair Guthrie, . . .